Bank-ready planning for pharma expansion

Problem statement

The business needed to achieve its growth targets in the regulated Ukrainian pharmaceutical wholesale market, deliver the expansion on time and on budget, and justify the proposed warehouse and working capital investments to a European bank.

The client needed credible long term financial projections, evidence of operational readiness, and a prudent, financeable strategy to support equity funding and sustainable market share growth.

‍

Approach

We ran a comprehensive market, operational and financial assessment. This included Ukrainian market and competitor analysis, regulatory review, SWOT and risk mapping; management, logistics, procurement and MIS due diligence; and validation of the warehouse and working capital programme. We conducted stakeholder interviews, built detailed financial projections, and stress tested scenarios. The output was a bank grade business plan and execution roadmap aligned to financing requirements.

‍

Results

Within eight weeks the company received an independent assessment and business plan covering market potential, competitive position, operational readiness, and investment feasibility. Our recommendations addressed governance, logistics and marketing refinements, with a phased roadmap and KPIs. The European bank approved a multi-million equity investment, enabling the client to pursue wholesale expansion with a clear plan, credible projections, and stronger investor confidence.

‍